ClinicalTrials.Veeva

Menu

Role of Negative Pressure Wound Therapy in Latissimus Dorsi Flap Donor Site Seroma Prevention

C

Chulalongkorn University

Status and phase

Completed
Phase 1

Conditions

Breast Reconstruction
NPWT
Latissimus Dorsi Flap

Treatments

Device: The negative pressure wound therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The use of NPWT as a post-operative dressing significantly reduces the incidence of seroma formation after harvesting LD flap.

Full description

NPWT was left in place on donor site with constant pressure between -125 and -80 mmHg to reduce seroma formation

Enrollment

40 patients

Sex

Female

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 20-60 years Underwent breast reconstruction with LD Flap

Exclusion criteria

  • Locally advanced cancer

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

NPWT group
Experimental group
Description:
Negative pressure wound therapy was used to prevent donor site seroma formation
Treatment:
Device: The negative pressure wound therapy
Control group
No Intervention group
Description:
Conventional method was used to the donor site

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems